Sputnik V impact on Panacea Biotec

24 במאי 2021

The production of Sputnik V, the COVID-19 vaccine granted emergency use authorisation, has been launched in India, said a joint statement issued by Russian Direct Investment Fund (RDIF) and pharmaceutical firm Panacea Biotec on May 24
I have came across this Ascending triangle, waiting for breakout !